Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

126.07
Delayed Data
As of Jun 23
 -0.16 / -0.13%
Today’s Change
96.18
Today|||52-Week Range
145.42
+3.04%
Year-to-Date
Top Stock Reports for Oracle, Allergan & Abbott
Jun 23 / Zacks.com - Paid Partner Content
Chipotle's Rally Could Resume
Jun 19 / TheStreet.com - Paid Partner Content
Biotech Insider Just Loaded Up $234 Million Worth the Stock
Jun 21 / TheStreet.com - Paid Partner Content
Company News for June 15, 2017
Jun 15 / Zacks.com - Paid Partner Content
Harbour Capital Advisors, LLC Buys iShares MSCI EAFE, Apple Inc, Exxon Mobil Corp, Se...
Jun 20 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug
Jun 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close126.23
Today’s open129.84
Day’s range124.95 - 130.02
Volume4,530,700
Average volume (3 months)2,769,632
Market cap$28.3B
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+14.87%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+21.11%
P/E ratio60.0
Price/Sales9.22
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.65+0.48%
ZTSZoetis Inc-0.73-1.15%
VRTXVertex Pharmaceutica...-2.03-1.50%
BAXBaxter International...+0.70+1.15%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts